Literature DB >> 10706719

Role of CCAAT/enhancer-binding protein site in transcription of human neutrophil peptide-1 and -3 defensin genes.

Y Tsutsumi-Ishii1, T Hasebe, I Nagaoka.   

Abstract

The human neutrophil defensins (human neutrophil peptides (HNPs)), major components of azurophilic granules, contribute to innate and acquired host immunities through their potent antimicrobial activities and ability to activate T cells. Despite being encoded by nearly identical genes, HNP-1 is more abundant in the granules than HNP-3. We investigated the regulation of HNP-1 and HNP-3 expression at the transcriptional level using a promyelocytic HL-60 cell line. Luciferase analysis showed that transcriptional levels of HNP-1 and HNP-3 promoters were equivalent and that an approximately 200-bp region identical between promoters was sufficient for transcriptional activity. Furthermore, overlapping CCAAT/enhancer-binding protein (C/EBP) and c-Myb sites in the region were found to be required for efficient transcription. Gel mobility shift assay demonstrated that C/EBPalpha predominantly bound to the C/EBP/c-Myb sites using HL-60 nuclear extracts. No specific binding to C/EBP/c-Myb sites was observed in nuclear extracts from mature neutrophils, which expressed neither C/EBPalpha protein nor HNP mRNAs. Taken together, these findings suggest that the difference in the amounts of HNP-1 and HNP-3 peptides in neutrophils is caused by posttranscriptional regulation and that C/EBPalpha plays an important role in the transcription of HNP genes in immature myeloid cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706719     DOI: 10.4049/jimmunol.164.6.3264

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1.

Authors:  Yutaka Kida; Takashi Shimizu; Koichi Kuwano
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.

Authors:  Daiju Okuda; Shin Yomogida; Hiroshi Tamura; Isao Nagaoka
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells.

Authors:  Yoko Tabe; Marina Konopleva; Rooha Contractor; Mark Munsell; Wendy D Schober; Linhua Jin; Yuko Tsutsumi-Ishii; Isao Nagaoka; Jun Igari; Michael Andreeff
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

4.  Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.

Authors:  Isao Nagaoka; Satoko Hirota; François Niyonsaba; Michimasa Hirata; Yoshiyuki Adachi; Hiroshi Tamura; Shigenori Tanaka; Didier Heumann
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

5.  Human α-defensin expression is not dependent on CCAAT/enhancer binding protein-ε in a murine model.

Authors:  Andreas Glenthøj; Sara Dahl; Maria T Larsen; Jack B Cowland; Niels Borregaard
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

Review 6.  Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases.

Authors:  Mariaimmacolata Preianò; Rocco Savino; Chiara Villella; Corrado Pelaia; Rosa Terracciano
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

7.  Manual annotation and analysis of the defensin gene cluster in the C57BL/6J mouse reference genome.

Authors:  Clara Amid; Linda M Rehaume; Kelly L Brown; James G R Gilbert; Gordon Dougan; Robert E W Hancock; Jennifer L Harrow
Journal:  BMC Genomics       Date:  2009-12-15       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.